Publications by authors named "Maggie Cheang"

Claim this Profile
S
Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study.
Milana Bergamino Sirvén, Elena López-Knowles, Xixuan Zhu, Holly Tovey, Lucy Kilburn, Maggie Chon U Cheang

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies.
Maggie Chon U Cheang, Mothaffar Rimawi, Stephen Johnston, Samuel A Jacobs, Judith Bliss

NPJ Breast Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
Chowdhury Arif Jahangir, David B Page, Glenn Broeckx, Claudia A Gonzalez, Caoimbhe Burke, Maggie Chon U Cheang

J Pathol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Holly Tovey, Orsolya Sipos, Joel S Parker, Katherine A Hoadley, Jelmar Quist, Maggie Chon U Cheang

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.
Joel S Parker, Michael Mullins, Maggie C U Cheang, Samuel Leung, David Voduc

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
David B Page, Glenn Broeckx, Chowdhury Arif Jahangir, Sara Verbandt, Rajarsi R Gupta, Maggie Chon U Cheang

J Pathol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.
Eugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, Lila Zabaglo, Elizabeth Folkerd, Maggie Chon U Cheang

Nat Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The proteomic landscape of soft tissue sarcomas.
Jessica Burns, Christopher P Wilding, Lukas Krasny, Xixuan Zhu, Madhumeeta Chadha, Maggie C U Cheang

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511.
Aruna Korlimarla, P S Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, Maggie Cheang

Transl Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
Aruna Korlimarla, Hari Ps, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, Maggie Cheang

Transl Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.
Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci, Joseph Ward, Richard Buus, Maggie Cheang

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer.
Milana A Bergamino, Elena López-Knowles, Gabriele Morani, Holly Tovey, Lucy Kilburn, Maggie C U Cheang

EBioMedicine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study.
Elena Lopez-Knowles, Simone Detre, Margaret Hills, Eugene F Schuster, Maggie C U Cheang

Breast Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial.
Robin L Jones, Vinod Ravi, Andrew S Brohl, Sant Chawla, Kristen N Ganjoo, Maggie Chon U Cheang

JAMA Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast Cancers.
Milana A Bergamino, Gabriele Morani, Joel Parker, Eugene F Schuster, Mariana F Leal, Maggie C U Cheang

Clin Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER/HER2 Breast Cancer.
Mitch Dowsett, Lucy Kilburn, Mothaffar F Rimawi, C Kent Osborne, Katherine Pogue-Geile, Maggie Cheang

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Ben P Haynes, Gene Schuster, Richard Buus, Anastasia Alataki, Ophira Ginsburg, Maggie Chon U Cheang

Breast Cancer Res Treat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx Digital Spatial Profiler.
Helga Bergholtz, Jodi M Carter, Alessandra Cesano, Maggie Chon U Cheang, Sarah E Church

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry.
Martina Milighetti, Lukas Krasny, Alex T J Lee, Gabriele Morani, Cornelia Szecsei, Maggie C U Cheang

J Proteomics· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.
Barrie Peck, Philip Bland, Ioanna Mavrommati, Gareth Muirhead, Hannah Cottom, Maggie C U Cheang

Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lights and Shadows in Immuno-Oncology Drug Development.
Milana Bergamino Sirvén, Sonia Pernas, Maggie C U Cheang

Cancers (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
Richard Buus, Zsolt Szijgyarto, Eugene F Schuster, Hui Xiao, Ben P Haynes, Maggie Chon U Cheang

NPJ Breast Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Ian Smith, John Robertson, Lucy Kilburn, Maggie Wilcox, Abigail Evans, Maggie Cheang

Lancet Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.
Elisa Fontana, Gift Nyamundanda, David Cunningham, Dongsheng Tu, Maggie C U Cheang

JCO Precis Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, Maggie C U Cheang

NPJ Breast Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis